Roger J. Garceau's most recent trade in Protara Therapeutics Inc was a trade of 24,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 12, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Protara Therapeutics Inc | Roger J. Garceau | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2025 | 24,000 | 24,000 | - | - | Stock Option (Right to Buy) | |
| Protara Therapeutics Inc | Roger J. Garceau | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2024 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| Entera Bio Ltd | Garceau Roger J. | Director | 01 Jan 2024 | 108,333 | 108,333 | - | - | Stock Option (right to buy) | ||
| Protara Therapeutics Inc | Roger J. Garceau | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| Entera Bio Ltd | Roger J. Garceau | Director | 02 Jan 2023 | 89,041 | 89,041 | - | - | Stock Option (right to buy) | ||
| Protara Therapeutics Inc | Roger J. Garceau | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| Entera Bio Ltd | Roger J. Garceau | Director | 01 Jan 2022 | 107,557 | 107,557 | - | - | Stock Option (right to buy) | ||
| Entera Bio Ltd | Roger J. Garceau | Director | 01 Jan 2022 | 35,852 | 35,852 | - | - | Stock Option (right to buy) | ||
| Protara Therapeutics Inc | Roger J. Garceau | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2021 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) |